Skip to main content

Table 1 Ad hoc C1-INH-HAE severity score

From: Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)

Severity score

Criteria

Asymptomatic

No angioedema episodes and no long-term

prophylactic treatment

Mild

No life-threatening angioedema episodes and no

long-term prophylactic treatment and ≤ 3

episodes/last 6 mos

Moderate

No life-threatening angioedema episodes

and

 ≤ 6 episodes/last 6 mos. with long-term

prophylactic treatment (except maintenance

treatment with pdC1-INH)

or

 > 4–12 episodes/last 6 mos. without long-term

prophylactic treatment

Severe

Life-threatening angioedema episodes

and/or

6 episodes/last 6 mos. with long-term

prophylactic treatment

and/or

Maintenance treatment with pdC1-INH

and/or

 > 12 episodes/last 6 mos. without long-term

prophylactic treatment

  1. C1-INH-HAE, Hereditary angioedema due to C1 inhibitor deficiency; pdC1-INH, plasma-derived C1 inhibitor concentrate; SD, standard deviation. (Copied from Prior et al. [5], with permission)